Published in AIDS Weekly, January 24th, 2000
Under the new award, the AACTG will receive $80 million in the first year of a 5-year grant. The funding enables the network to continue conducting studies of antiviral interventions, methods to reconstitute the immune system damaged by HIV, and the treatment and prevention of opportunistic diseases and other HIV related complications.
"Since the beginning of the AIDS epidemic, the AACTG has made enormous contributions in helping people with HIV live...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.